title: Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering
source: Yahoo
date: 2025-10-22
url: https://finnhub.io/api/news?id=d7bf95b7ba08ac3c5820b8bb877ca6123fad7e7bcce97a5bc77713118a0a4699
New Spherix Global Insights data reveal growing physician demand for therapies that reduce treatment burden and elevate patient experience.EXTON, PA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Hematologists across the United States are redefining what “success” looks like in hemophilia treatment, according to the latest findings from Market Dynamix™: Hemophilia (US) 2025 and the accompanying Launch Dynamix™ trackers for Qfitlia (Sanofi), Hympavzi (Pfizer), and Alhemo (Novo Nordisk). The new research from
